Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto
AssigneeThe Regents of the University of California
InventorAnahid Jewett
Life of this patent
Estimating the term…
Abstract
The present application relates to probiotic compositions, e.g., comprising at least one bacterial strain selected from: Streptococcus thermophilus, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, KE99, and Lactobacillus bulgaricus, optionally wherein the at least one bacterial strain is either alive or sonicated.
Claims18
A method of treating cancer or a cancer-related disease or disorder in a subject having or suspected of having a cancer or cancer-related disease or disorder, comprising administering to the subject
- (a) a therapeutically effective amount of a composition comprising bacterial strains of:
- Streptococcus thermophilus, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, and Lactobacillus paracasei;
- and
- (b) a therapeutically effective amount of a composition comprising:
- (i) at least one NK cell;
- and/or
- (ii) at least one non-NK cell that is capable of activating an NK cell.
Dependencies are inferred from the claim text.